2022. Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer. Biomolecules and Biomedicine. 22, 4 (Jul. 2022), 553–559. DOI:https://doi.org/10.17305/bjbms.2021.6450.